NASDAQ · LAB
Standard BioTools Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for LAB: Nov 3, 2026
Standard BioTools Inc. Common Stock is estimated to report earnings on 11/03/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.06.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Zacks · Fintel- RTTNews · Oct 5, 5:04 PM EDTStandard Biotools Agrees To Sell Microfluidics Business To ARCHIMED(RTTNews) – On Monday, Standard BioTools Inc. (NASDAQ: LAB) announced that it has signed a definitive agreement to sell its Microfluidics business to ARCHIMED, an investment firm focused on the healthcare industry.
- The Motley Fool · Aug 31, 5:04 AM EDTJohnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.J&J's portfolio primarily includes small biotech and medtech companies.
- RTTNews · Aug 25, 1:55 PM EDTStandard BioTools Reports Q2 2026 Results, Revenue Declines; Adjusted EBITDA Improves 84%(RTTNews) – Standard BioTools Inc. (LAB), a provider of next-generation tools and technologies for life sciences research, recently reported financial results for the second quarter ended June 30, 2026, while continuing to advance its planned merger with Treeline Biosciences.
- RTTNews · Aug 5, 4:33 PM EDTStandard BioTools Inc. Q2 Loss Declines(RTTNews) – Standard BioTools Inc. (LAB) reported Loss for second quarter of -$26.758 million
- RTTNews · Jun 8, 8:28 AM EDTStandard BioTools Signs Deal To Merge With Treeline Biosciences(RTTNews) – Monday, Standard BioTools Inc. (LAB) announced an agreement with Treeline Biosciences, Inc., a clinical-stage biopharma company, to combine in an all-stock transaction.
- Zacks · May 5, 8:30 PM EDTStandard BioTools (LAB) Reports Q1 Loss, Tops Revenue EstimatesStandard BioTools (LAB) delivered earnings and revenue surprises of 0.00% and +13.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Jan 8, 7:25 AM ESTStandard BioTools Reports Preliminary Q4, Full-Year Revenue(RTTNews) – Standard BioTools Inc. (LAB), a life science tools company, on Thursday announced preliminary revenue results for the fourth quarter and full-year 2025.
- RTTNews · Nov 27, 11:50 PM ESTMODD, LAB, HOWL, COGT, LGVN, ABCL Lead Biotech After-Hours Rally – Nov 26(RTTNews) – Several biotech and life sciences companies posted notable gains in after-hours trading on Wednesday, November 26, reflecting investor interest despite a relatively quiet news cycle.
- RTTNews · Nov 12, 11:07 PM ESTAfter-Hours Gainers: MGNX, SLS, KRMD, HYPR, WVE Post Sharp Moves Following Q3 Updates(RTTNews) – Several small-cap healthcare and biotech names posted notable price increases in after-hours trading on Wednesday, following earnings updates or ahead of scheduled financial disclosures.
- Fintel · Nov 5, 6:34 PM ESTTD Cowen Maintains Standard BioTools (LAB) Hold RecommendationFintel reports that on November 5, 2025, TD Cowen maintained coverage of Standard BioTools (NasdaqGS:LAB) with a Hold recommendation. Analyst Price Forecast Suggests 60.22% Upside
- Zacks · Aug 11, 7:00 PM EDTStandard BioTools (LAB) Reports Q2 Loss, Tops Revenue EstimatesStandard BioTools (LAB) delivered earnings and revenue surprises of 0.00% and +5.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 7, 5:30 PM EDTDoximity (DOCS) Q1 Earnings and Revenues Top EstimatesDoximity (DOCS) delivered earnings and revenue surprises of +16.13% and +4.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Standard BioTools Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.